HOME >> BIOLOGY >> NEWS
Viruses found in untreated city water

LA CROSSE, Wis. - Viruses from human sources occur in the La Crosse, Wisconsin municipal drinking water supply prior to its chlorination, according to a study published today in the scientific journal Applied and Environmental Microbiology. Although the city's treated water meets or exceeds state and federal standards for drinking water, researchers and public health officials agree that more study is needed to pinpoint sources of the viruses and to determine if some viruses are surviving chlorination and making people sick with diarrhea and vomiting.

The objective of the study, by Marshfield Clinic Research Foundation (MCRF) and the U.S. Geological Survey (USGS), was to determine whether the amount of Mississippi River water moving through the riverbank and infiltrating city wells was related to the frequency of virus detection in the wells.

"There is a misconception that groundwater is pure because it is filtered simply by the process of passing through the soil, but that isn't always the case," said Mark Borchardt, Ph.D., the study's lead investigator and a scientist in MCRF's National Farm Medicine Center. "Understanding viruses in groundwater is a research priority among drinking water professionals. La Crosse is leading the way and has the most extensive dataset of any community in the U.S. that uses groundwater as its drinking water source." Researchers tested 48 untreated water samples from six of the city's 15 wells to evaluate whether viruses were present in the raw water. Half of the water samples contained at least one type of gastrointestinal virus and 23 percent of the samples contained two or more virus types. The study found enteroviruses, rotavirus, hepatitis A virus and noroviruses. Besides noting the presence of these viruses with molecular testing methods, researchers attempted to culture the enteroviruses and hepatitis A viruses to see if they were infectious. None of the enteroviruses sampled were infectious, althoug
'"/>

Contact: Chris Schellpfeffer
cschell@lsb.com
608-251-7070
Marshfield Clinic
6-Oct-2004


Page: 1 2 3

Related biology news :

1. The sweet science: Viruses switch grip to gain upper hand
2. Viruses can jump between primates and humans, researchers warn
3. Viruses may one day help treat brain tumors
4. Waters off Washington state only second place in world where glass sponge reefs found
5. First new multiple sclerosis gene found in 30 years
6. Obesity found to be a risk factor for multiple myeloma
7. Antibody-altering protein found in developing B cells
8. New use for a cell toxin found to inhibit survival proteins in cancer cells
9. New way to target and kill antibiotic-resistant bacteria found
10. Soil particles found to boost prions capacity to infect
11. Support for chromosomal theory of cancer found in cancers development of drug resistance

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Viruses found untreated city water

(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: